Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Revenues for Granules India Limited are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 1.555000
forwardPE 16.482443
debtToEquity 39.153000
earningsGrowth 0.173000
revenueGrowth 0.018000
grossMargins 0.614940
operatingMargins 0.157720
trailingEps 20.690000
forwardEps 0.000000

GRANULES's current ratio of 1.555 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as GRANULES can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
GRANULES's Forward PE is within a good range, showing that the stock price compares well to its earnings. This suggests it isn't overpriced and leaves room for growth, making the stock appealing to investors looking for value and growth opportunities.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

The price of GRANULES currently aligns with projections, offering no clear risks or opportunities. This situation suggests stability in the stock's performance, leading investors to await further developments before making strategic decisions.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


A recent buy bias from analysts toward GRANULES may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that GRANULES might be an appealing option for those looking to grow their wealth through stock market investments.